XML 19 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2022
Apr. 05, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-00100    
Entity Registrant Name THERAPEUTICSMD, INC.    
Entity Central Index Key 0000025743    
Entity Tax Identification Number 87-0233535    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 951 Yamato Road,    
Entity Address, Address Line Two Suite 220    
Entity Address, City or Town Boca Raton    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33431    
City Area Code 561    
Local Phone Number 961-1900    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol TXMD    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 87,323,238
Entity Common Stock, Shares Outstanding   9,953,290  
ICFR Auditor Attestation Flag false    
Auditor Firm ID 248    
Auditor Name GRANT THORNTON LLP    
Auditor Location Miami, Florida    
Documents Incorporated by Reference

Documents Incorporated by Reference

 

Portions of the registrant’s definitive Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Proxy Statement will be filed with the Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year ended December 31, 2022.